TENX

Tenax Therapeutics Inc

TENX.US tenaxthera.com + Research + Basket
CIK 0000034956
Employees 14
Phone 919 855 2100
Fiscal year end December
IPO Jan 02, 1997
Address 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517
1.63
-0.18 (-9.94%)
USD · NASDAQ
52-week range
1.31
19.40
Trading at 2% of the 52-week range
Market Cap
67.74M
P/E Ratio
0.00
Forward P/E
0.30
Book Value
2.19
Div. Yield
N/A
% Institutions
114.95%
% Insiders
0.180%

1 Year

-77.0%

3 Year

-89.0%

10 Year

-100.0%
Description

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

Actions

Add an action for TENX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Christopher T. Giordano CEO, President & Director 1975
Mr. Thomas A. McGauley Principal Financial Officer & Principal Accounting Officer 1973
Dr. Stuart Rich M.D. Chief Medical Officer & Director 1950
Mr. Thomas R. Staab II, CPA Chief Financial Officer 1968
Mr. Doug Randall Chief Business Officer NA
Dr. Douglas Hay Ph.D. Executive Vice President of Regulatory Affairs NA
Mr. Timothy G. Healey M.B.A. Chief Commercial Officer 1966
Dr. So-Young Kim M.D. Executive Vice President of Clinical Development & Strategy NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 08, 2025 Stuart Rich N/A Purchase 2.50K $10.10 $25.25K SEC
Dec 04, 2025 Stuart Rich N/A Purchase 2.50K $9.20 $23.00K SEC
Dec 03, 2025 Stuart Rich N/A Purchase 1.50K $9.08 $13.62K SEC
Dec 02, 2025 Stuart Rich N/A Purchase 1.00K $9.01 $9.01K SEC
Nov 20, 2025 Christopher Thomas Giordano N/A Purchase 538.00 $7.59 $4.08K SEC
Nov 19, 2025 Christopher Thomas Giordano N/A Purchase 455.00 $7.51 $3.42K SEC
Nov 18, 2025 Christopher Thomas Giordano N/A Purchase 1.61K $7.75 $12.49K SEC
Nov 17, 2025 Thomas Mcgauley N/A Purchase 2.00K $7.34 $14.68K SEC
Nov 17, 2025 Thomas Mcgauley N/A Purchase 6.00K $7.25 $43.50K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 3.94M Jun 30, 2026 10.53% $0.00 1,122.06%
Vivo Capital, LLC 2.50M Jun 30, 2026 6.68% $3.32 1,100.00%
BlackRock Inc 1.73M Jun 30, 2026 4.62% $0.00 10,078.41%
Perceptive Advisors LLC 1.70M Jun 30, 2026 4.54% $0.37 17.42%
Vanguard Capital Management, LLC 1.15M Jun 30, 2026 3.07% $0.00 335.47%
Millennium Management LLC 876.23K Jun 30, 2026 2.34% $0.00 64.12%
Ikarian Capital, LLC 787.60K Jun 30, 2026 2.10% $1.23 -22.60%
Candriam Luxembourg S.C.A. 749.59K Jun 30, 2026 2.00% $0.05 0.00%
Citadel Advisors Llc 728.56K Jun 30, 2026 1.95% $0.00 377.69%
RTW INVESTMENTS, LLC 696.57K Jun 30, 2026 1.86% $0.09 88.14%
Stonepine Capital Management Llc 660.00K Jun 30, 2026 1.76% $5.42 -32.32%
Geode Capital Management, LLC 639.54K Jun 30, 2026 1.71% $0.00 824.72%
T. Rowe Price Associates, Inc. 607.66K Jun 30, 2026 1.62% $0.00 -79.41%
Marshall Wace Asset Management Ltd 585.58K Jun 30, 2026 1.56% $0.01 66.09%
BRAIDWELL LP 584.41K Jun 30, 2026 1.56% $0.31 0.00%
Point72 Asset Management, L.P. 556.76K Jun 30, 2026 1.49% $0.01 4.27%
Velan Capital Investment Management LP 549.99K Jun 30, 2026 1.47% $4.87 -5.72%
Adage Capital Partners Gp LLC 540.13K Jun 30, 2026 1.44% $0.01 0.00%
Woodline Partners LP 531.25K Jun 30, 2026 1.42% $0.02 64.01%
State Street Corp 510.81K Jun 30, 2026 1.36% $0.00 1,662.04%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 898.56K 2.40% ▼ 0.40% Oct 29, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 852.26K 2.28% ▲ 0.00% Sep 30, 2026
3 Fidelity Advisor Biotechnology I 445.10K 1.19% ▲ 0.00% Aug 31, 2026
4 Fidelity Small Cap Discovery 335.02K 0.90% ▲ 6.67% Jul 31, 2026
5 iShares Russell 2000 Value ETF 332.69K 0.89% ▼ 0.31% Oct 28, 2026
6 Fidelity Series Small Cap Discovery 299.10K 0.80% ▲ 6.40% Jul 31, 2026
7 Fidelity Series Small Cap Core 282.40K 0.75% ▲ 0.00% Jul 31, 2026
8 Fidelity Small Cap Index 275.70K 0.74% ▲ 0.88% Jul 31, 2026
9 Vanguard Russell 2000 ETF 211.67K 0.57% ▲ 46.78% Sep 30, 2026
10 CREF Total Global Stock Account R3 126.32K 0.34% ▼ 12.51% Aug 31, 2026

Financial Highlights

▼
Market Cap: $67.74M
EBITDA: $-19.49M
PEG Ratio: $1.44
Book Value: $2.19
Earnings/Share: $-1.48
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -37.70%
ROE (TTM): -59.80%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-50.24M
Trailing P/E: 0.00
Forward P/E: 0.30

Shares Statistics

Shares Outstanding: 37.42M
Shares Float: 29.86M
% Insiders: 0.180%
% Institutions: 114.95%
Shares Short: 7.23M
Shares Short (Prior Month): 7.18M
Short Ratio: 2.73
Short % Float: 19.48%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-23.71M
R&D
adjust
$-32.67M
Operating Income
subtotal
$-56.39M
Other / Non-Operating Items
adjust
$3.79M
Net Income
subtotal
$-52.60M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TENX.US!